Omada Health (OMDA) insider Sean Duffy files to sell 8,628 shares

Rhea-AI Filing Summary

Omada Health, Inc. insider Sean Duffy filed a notice to sell common stock. The filing lists a planned sale of 8,628 common shares on 08/07/2026, to be issued through an exercise of stock options for cash. It also details multiple prior Rule 10b5-1 sales of common stock between June and August 2026, each with specified share amounts and aggregate proceeds.

Key Figures

Planned shares to be sold: 8,628 shares Aggregate amount for 08/03/2026 sale: 264,007.12 Aggregate amount for 07/01/2026 sale: 293,787.38 +3 more

6 metrics

Planned shares to be sold 8,628 shares Common stock associated with exercise of stock options on 08/07/2026

Aggregate amount for 08/03/2026 sale 264,007.12 Rule 10b5-1 sale of common stock on 08/03/2026

Aggregate amount for 07/01/2026 sale 293,787.38 Rule 10b5-1 sale of common stock on 07/01/2026

Aggregate amount for additional 07/01/2026 sale 293,435.69 Second Rule 10b5-1 sale of common stock on 07/01/2026

Aggregate amount for 06/16/2026 sale 259,711.58 Rule 10b5-1 sale of common stock on 06/16/2026

Shares sold on 06/16/2026 14,960 shares Rule 10b5-1 sale of OMDA common stock

Key Terms

Form 144, Rule 10b5-1, Exercise of Stock Options, Executive Financial Services

4 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Rule 10b5-1 regulatory

"10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Exercise of Stock Options financial

"Common | 08/07/2026 | Exercise of Stock Options | Issuer"

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 04:36 PM Accepted by SEC EDGAR 08/07/2026 - 04:35 PM Learn about SEC filing dates

FAQ

What does OMDA’s Form 144 filing by Sean Duffy disclose?

The filing discloses a planned sale of 8,628 common shares of Omada Health, Inc. tied to an exercise of stock options on 08/07/2026, plus a list of prior Rule 10b5-1 sales over the prior three months.

How many OMDA shares are planned for sale in the new Form 144 notice?

The Form 144 indicates a planned sale of 8,628 common shares of Omada Health, Inc. The shares are to be acquired via exercise of stock options for cash with an intended sale date of 08/07/2026 on NASDAQ.

What recent 10b5-1 sales of OMDA stock are listed for Sean Duffy?

The filing lists multiple Rule 10b5-1 sales of OMDA common stock, including transactions on 06/16/2026, 06/24/2026, 06/25/2026, 06/26/2026, 07/01/2026 and 08/03/2026, each with specified share counts and aggregate dollar amounts.

Is Sean Duffy’s planned OMDA stock sale under a Rule 10b5-1 plan?

The document identifies prior transactions specifically as 10b5-1 sales, but the planned 8,628-share sale on 08/07/2026 is described as an exercise of stock options and is not labeled in this excerpt as a 10b5-1 trade.

On which market is the planned OMDA stock sale expected to occur?

The planned sale of 8,628 common shares of Omada Health, Inc. associated with the option exercise dated 08/07/2026 is identified as being for trading on NASDAQ, according to the securities information section.

What aggregate dollar amounts are associated with recent OMDA 10b5-1 sales?

Listed 10b5-1 transactions for OMDA common stock include aggregate amounts such as 264,007.12 on 08/03/2026, 293,787.38 and 293,435.69 on 07/01/2026, and 259,711.58 on 06/16/2026, among other entries.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	8628	168591.12	59448507	08/07/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/07/2026	Exercise of Stock Options	Issuer			8628	08/07/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	08/03/2026	12944	264007.12
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	07/01/2026	12944	293787.38
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	07/01/2026	12942	293435.69
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	06/26/2026	9844	193013.28
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	06/26/2026	4314	90162.60
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	06/25/2026	300	5700.99
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	06/24/2026	2800	53238.92
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	06/16/2026	14960	259711.58

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)